← FDA DRUG APPROVALS

FDA ANDA · ANDA211477

FLUOXETINE HYDROCHLORIDE

Sponsor: SOMERSET THERAPS LLC

APPLICATION
ANDA211477
TYPE
ANDA
ORIGINAL APPROVAL
2018-11-21
LATEST ACTION
2024-08-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

FLUOXETINE HYDROCHLORIDEPrescription
FLUOXETINE HYDROCHLORIDE EQ 60MG BASE · TABLET · ORAL

Approval history

2024-08-29Labeling · Supplement 3 · standardAP
2024-08-29Labeling · Supplement 2 · standardAP
2018-11-21UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →